KRAS and cancer: Notably, diverse cancer cell lines and tissues from patients with cancer showed a close association between KRAS and DX2 levels (Fig. 1g, h), suggesting that patients with high KRAS and DX2 levels could respond more sensitively to the inhibition of the KRAS and DX2 interaction than those with low levels of the two proteins.